Top

Published in:

01-07-2016 | Editorial

Into Action: Improving Access to Optimum Care for all Primary Immunodeficiency Patients

Authors: Francisco J. Espinosa-Rosales, Antonio Condino-Neto, José L. Franco, Ricardo U. Sorensen

Published in: Journal of Clinical Immunology | Issue 5/2016

Excerpt

Primary Immunodeficiency (PI) is a group of over 300 inborn defects of the immune system, both in its hematopoietic as well as in its non-hematopoietic components. They can present with a broad spectrum of clinical features, either with infections (recurrent common or common lifethreatening or rare lifethreatening), autoinflammation, autoimmunity, malignancy, and or allergy. Previously classified as ‘rare diseases’ PI are no longer as rare as previously thought: today, it is estimated that PI affects more than six million people worldwide, with no gender, age or geographical boundaries. …

http://www.who.int/medicines/publications/essentialmedicines/EMLc_2015_FINAL_amended_AUG2015.pdf?ua=1 consulted on November 20, 2015.

http://www.who.int/selection_medicines/committees/expert/20/EML_2015_FINAL_amended_AUG2015.pdf?ua=1 consulted on November 20, 2015.

Clément MC, Mahlaoui N, Mignot C, Le Bihan C, Rabetrano H, Hoang L, Neven B, Moshous D, Cavazzana M, Blanche S, Fischer A, Audrain M, Durand-Zaleski I. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data. J Allergy Clin Immunol. 2015;135:1589–93.CrossRefPubMed

Ghosh S, Thrasher AJ, Gaspar HB. Gene therapy for monogenic disorders of the bone marrow. Br J Haematol. 2015. doi:10.1111/bjh.13520.

Principles of Care for Primary Immunodeficiencies http://journal.frontiersin.org/article/10.3389/fimmu.2014.00627/full

Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, Abel L. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1):1–7.CrossRefPubMed

Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012;1250:62–72.CrossRefPubMed

Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497–502.CrossRefPubMed

Title: Into Action: Improving Access to Optimum Care for all Primary Immunodeficiency Patients
Authors: Francisco J. Espinosa-Rosales
Antonio Condino-Neto
José L. Franco
Ricardo U. Sorensen
Publication date: 01-07-2016
Publisher: Springer US
Published in: Journal of Clinical Immunology / Issue 5/2016
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-016-0277-2

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Into Action: Improving Access to Optimum Care for all Primary Immunodeficiency Patients

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2016

Recent Advances in DOCK8 Immunodeficiency Syndrome

Successful Hematopoietic Stem Cell Transplantation in a Patient with LPS-Responsive Beige-Like Anchor (LRBA) Gene Mutation

Erratum to: Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency

Successful Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in a Severe Combined Immune Deficiency Patient: a First Report

Hyper IgM Syndrome: a Report from the USIDNET Registry

Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page